Literature DB >> 2123292

Multiple cis- and trans-acting elements involved in regulation of the neu gene.

T C Suen1, M C Hung.   

Abstract

A 2.4-kb rat neu genomic DNA fragment that hybridized to the 5'-most coding sequence of the rat neu cDNA was cloned. S1 nuclease mapping identified multiple transcriptional initiation sites. DNA sequence analysis revealed that this fragment contained 64 bp of the first intron, 81 bp of the first exon, and the upstream noncoding sequence of the neu gene. The sequence immediately upstream of the translation start site was G + C rich (greater than 75%) and contained a consensus CCAAT sequence despite the absence of a TATA box. An Sp1-binding site was found, in addition to various sequence motifs common to the promoters of the human neu gene (erbB2), the epidermal growth factor receptor gene, and the simian virus 40 enhancer. A 2.2-kb EcoRI-Narl fragment containing sequences upstream from the 3'-most transcriptional start site was fused to the bacterial chloramphenicol acetyltransferase reporter gene and shown to promote transcription efficiently. A series of promoter deletion constructs was made, and results from transfection and subsequent chloramphenicol acetyltransferase assays suggested the presence of multiple cis-acting elements that contributed either positively or negatively to the transcription activity. Cotransfection competition experiments using subcloned cis-acting elements confirmed the existence of trans-acting factors interacting with these DNA fragments. In addition, a gel retardation assay was performed to demonstrate the physical binding of nuclear factors to certain fragments. The results complemented those of the deletion studies and led us to conclude that transcriptional regulation of the neu proto-oncogene involves at least one negative and three positive trans-acting factors interacting with different cis-acting elements along the neu gene promoter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123292      PMCID: PMC362906          DOI: 10.1128/mcb.10.12.6306-6315.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  64 in total

1.  Expression of the c-erbB-2 gene product (p185) at different stages of neoplastic progression in the colon.

Authors:  J D'Emilia; K Bulovas; K D'Ercole; B Wolf; G Steele; I C Summerhayes
Journal:  Oncogene       Date:  1989-10       Impact factor: 9.867

Review 2.  Eukaryotic transcriptional regulatory proteins.

Authors:  P F Johnson; S L McKnight
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements.

Authors:  T Edlund; M D Walker; P J Barr; W J Rutter
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

4.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

5.  Characterization of the promoter region and 3' end of the human insulin receptor gene.

Authors:  D S Tewari; D M Cook; R Taub
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.157

6.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

7.  A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

Authors:  K Semba; N Kamata; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.

Authors:  S Ishii; Y H Xu; R H Stratton; B A Roe; G T Merlino; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.

Authors:  A L Schechter; M C Hung; L Vaidyanathan; R A Weinberg; T L Yang-Feng; U Francke; A Ullrich; L Coussens
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

10.  Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).

Authors:  Y Suda; S Aizawa; Y Furuta; T Yagi; Y Ikawa; K Saitoh; Y Yamada; K Toyoshima; T Yamamoto
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

View more
  10 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Negative autoregulation of the neu gene is mediated by a novel enhancer.

Authors:  X Y Zhao; M C Hung
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Identification and characterization of a novel enhancer for the rat neu promoter.

Authors:  D H Yan; M C Hung
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Variation in expression of the Haemophilus influenzae HMW adhesins: a prokaryotic system reminiscent of eukaryotes.

Authors:  S Dawid; S J Barenkamp; J W St Geme
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

5.  c-myc reverses neu-induced transformed morphology by transcriptional repression.

Authors:  T C Suen; M C Hung
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

6.  Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development.

Authors:  Y J Ma; D F Hill; K E Creswick; M E Costa; A Cornea; M N Lioubin; G D Plowman; S R Ojeda
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

Review 7.  The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.

Authors:  Katie Lin; Stavroula Baritaki; Silvia Vivarelli; Luca Falzone; Aurora Scalisi; Massimo Libra; Benjamin Bonavida
Journal:  Antioxidants (Basel)       Date:  2022-06-17

8.  Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.

Authors:  Prudence B Lam; Laura N Burga; Bryan P Wu; Erin W Hofstatter; Kun Ping Lu; Gerburg M Wulf
Journal:  Mol Cancer       Date:  2008-12-15       Impact factor: 27.401

9.  A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.

Authors:  D P Hollywood; H C Hurst
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

10.  GmWRKY40, a member of the WRKY transcription factor genes identified from Glycine max L., enhanced the resistance to Phytophthora sojae.

Authors:  Xiaoxia Cui; Qiang Yan; Shuping Gan; Dong Xue; Haitang Wang; Han Xing; Jinming Zhao; Na Guo
Journal:  BMC Plant Biol       Date:  2019-12-30       Impact factor: 4.215

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.